Facile preparation of internally self-assembled lipid particles stabilized by carbon nanotubes

Journal of Visualized Experiments

Volumn 2016, Issue 108, 2016, Pages

  Patil Sen, Yogita ^a   Sadeghpour, Amin ^b   Rappolt, Michael ^b   Kulkarni, Chandrashekhar V ^a  

^a UNIVERSITY OF CENTRAL LANCASHIRE   (United Kingdom)

^b UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

Biocompatibility; Carbon nanotubes; Chemistry; Coating carbon nanotubes; Drug delivery; Hybrid systems; Issue 108; Lipid nanostructures; Lipid self assembly; Nanocarriers; Nanostructured lipid particles; O W emulsion; Pickering emulsion

Indexed keywords

CARBON NANOTUBE; EMULSION; LIPID; NANOCAPSULE; NANOMATERIAL;

CHEMISTRY; DRUG FORMULATION; DRUG STABILITY; EMULSION; KINETICS; PROCEDURES; RAMAN SPECTROMETRY; ULTRASTRUCTURE;

DRUG COMPOUNDING; DRUG STABILITY; EMULSIONS; KINETICS; LIPIDS; NANOCAPSULES; NANOSTRUCTURES; NANOTUBES, CARBON; SPECTRUM ANALYSIS, RAMAN;

EID: 84959539277     PISSN: 1940087X     EISSN: None     Source Type: Journal    
DOI: 10.3791/53489     Document Type: Article

References (73)

1. Peer, D. et al. Nanocarriers as an emerging platform for cancer therapy. Nature Nanotech. 2, 751-760 (2007).
2. White, R. R., Sullenger, B. A., & Rusconi, C. P. Developing aptamers into therapeutics. J. Clin. Invest. 106, 929-934 (2000).
3. Itaka, K., Chung, U.-I., & Kataoka, K. Supramolecular nanocarrier for gene and siRNA delivery. Nippon Rinsho Jpn. J. Clin. Med. 64, 253-257 (2006).
4. Xu, S. et al. Development of pH-responsive core-shell nanocarriers for delivery of therapeutic and diagnostic agents. Bioorg. Med. Chem. Lett. 19, 1030-1034 (2009).
5. Soppimath, K. S., Tan, D. C. W., & Yang, Y. Y. pH-triggered thermally responsive polymer core-shell nanoparticles for drug delivery. Adv. Mater. 17, 318-323 (2005).
6. Hans, M., & Lowman, A. Biodegradable nanoparticles for drug delivery and targeting. Curr. Opin. Solid State Mater. Sci. 6, 319-327 (2002).
7. Petros, R. A., & DeSimone, J. M. Strategies in the design of nanoparticles for therapeutic applications. Nat Rev Drug Discov. 9, 615-627 (2010).
8. Torchilin, V. P. Multifunctional nanocarriers. Adv Drug Deliver Rev. 64, 302-315 (2012).
9. Shmeeda, H. et al. Delivery of zoledronic acid encapsulated in folate-targeted liposome results in potent in vitro cytotoxic activity on tumor cells. J. Controlled Release. 146, 76-83 (2010).
10. Xu, Z. et al. The performance of docetaxel-loaded solid lipid nanoparticles targeted to hepatocellular carcinoma. Biomaterials. 30, 226-232 (2009).
11. Rosenthal, E. et al. Phase IV study of liposomal daunorubicin (DaunoXome) in AIDS-related Kaposi sarcoma. Am. J. Clin. Oncol.-Canc. 25, 57-59 (2002).
12. Dong, Y. D., Larson, I., Bames, T. J., Prestidge, C. A., & Boyd, B. J. Adsorption of Nonlamellar Nanostructured Liquid-Crystalline Particles to Biorelevant Surfaces for Improved Delivery of Bioactive Compounds. Acs Appl Mater Inter. 3, 1771-1780 (2011).
13. Rizwan, S. B., Boyd, B. J., Rades, T., & Hook, S. Bicontinuous cubic liquid crystals as sustained delivery systems for peptides and proteins. Expert Opin. Drug. Deliv. 7, 1133-1144 (2010).
14. Yoo, H. S., & Park, T. G. Folate receptor targeted biodegradable polymeric doxorubicin micelles. J. Controlled Release. 96, 273-283 (2004).
15. Khandare, J. J. et al. Dendrimer versus linear conjugate: Influence of polymeric architecture on the delivery and anticancer effect of paclitaxel. Bioconjug. Chem. 17, 1464-1472 (2006).
16. Prabaharan, M., Grailer, J. J., Pilla, S., Steeber, D. A., & Gong, S. Gold nanoparticles with a monolayer of doxorubicin-conjugated amphiphilic block copolymer for tumor-targeted drug delivery. Biomaterials. 30, 6065-6075 (2009).
17. Fan, J. et al. Targeted anticancer prodrug with mesoporous silica nanoparticles as vehicles. Nanotechnology. 22 (2011).
18. Bianco, A., & Prato, M. Can carbon nanotubes be considered useful tools for biological applications? Adv. Mater. 15, 1765-1768 (2003).
19. Kam, N. W. S., & Dai, H. J. Carbon nanotubes as intracellular protein transporters: Generality and biological functionality. J. Am. Chem. Soc. 127, 6021-6026 (2005).
20. Kulkarni, C. V. Lipid crystallization: from self-assembly to hierarchical and biological ordering. Nanoscale. 4, 5779-5791 (2012).
21. Yaghmur, A. et al. Drug Formulations Based on Self-Assembled Liquid Crystalline Nanostructures. CRC Press 341-360 (2014).
22. Kulkarni, C. V. in Advances in Planar Lipid Bilayers and Liposomes. Academic Press Vol. 12 237-272 (2010).
23. Landau, E. M., & Navarro, J. V. Application: US Pat, US2001/0025791A1. (2001).
24. Kulkarni, C., Belsare, N., & Lele, A. Studies on shrikhand rheology. J. Food Eng. 74, 169-177 (2006).
25. Mezzenga, R., Schurtenberger, P., Burbidge, A., & Michel, M. Understanding foods as soft materials. Nature Mater. 4, 729-740 (2005).
26. Ubbink, J., Burbidge, A., & Mezzenga, R. Food structure and functionality: a soft matter perspective. Soft Matter. 4, 1569-1581 (2008).
27. Dong, Y.-D., Larson, I., Hanley, T., & Boyd, B. J. Bulk and dispersed aqueous phase behavior of phytantriol: effect of vitamin E acetate and F127 polymer on liquid crystal nanostructure. Langmuir. 22, 9512-9518 (2006).
28. Yaghmur, A., & Glatter, O. Characterization and potential applications of nanostructured aqueous dispersions. Adv. Colloid Interface Sci. 147, 333-342 (2009).
29. Pardeike, J., Hommoss, A., & Müller, R. H. Lipid nanoparticles (SLN, NLC) in cosmetic and pharmaceutical dermal products. Int. J. Pharm. 366, 170-184 (2009).
30. Yaghmur, A., Rappolt, M., Østergaard, J., Larsen, C., & Larsen, S. W. Characterization of bupivacaine-loaded formulations based on liquid crystalline phases and microemulsions: the effect of lipid composition. Langmuir. 28, 2881-2889 (2012).
31. Singh, H., Ye, A., & Horne, D. Structuring food emulsions in the gastrointestinal tract to modify lipid digestion. Prog. Lipid Res. 48, 92-100 (2009).
32. Angelova, A., Angelov, B., Mutafchieva, R., Lesieur, S., & Couvreur, P. Self-Assembled Multicompartment Liquid Crystalline Lipid Carriers for Protein, Peptide, and Nucleic Acid Drug Delivery. Accounts Chem. Res. 44, 147-156 (2011).
33. Clogston, J., & Caffrey, M. Controlling release from the lipidic cubic phase. Amino acids, peptides, proteins and nucleic acids. J. Controlled Release. 107, 97-111 (2005).
34. Shah, J. C., Sadhale, Y., & Chilukuri, D. M. Cubic phase gels as drug delivery systems. Adv. Drug Deliver. Rev. 47, 229-250 (2001).
35. Boyd, B. J., Whittaker, D. V., Khoo, S. M., & Davey, G. Lyotropic liquid crystalline phases formed from glycerate surfactants as sustained release drug delivery systems. Int. J. Pharm. 309, 218-226 (2006).
36. Drummond, C. J., & Fong, C. Surfactant self-assembly objects as novel drug delivery vehicles. Curr. Opin. Colloid Interface Sci. 4, 449-456 (1999).
37. Zhao, X. Y., Zhang, J., Zheng, L. Q., & Li, D. H. Studies of cubosomes as a sustained drug delivery system. J. Dispersion Sci. Technol. 25, 795-799, (2004).
38. Malmsten, M. Phase transformations in self-assembly systems for drug delivery applications. J. Dispersion Sci. Technol. 28, 63-72 (2007).
39. Sadhale, Y., & Shah, J. C. Stabilization of insulin against agitation-induced aggregation by the GMO cubic phase gel. Int. J. Pharm. 191, 51-64 (1999).
40. Amar-Yuli, I., Azulay, D., Mishraki, T., Aserin, A., & Garti, N. The role of glycerol and phosphatidylcholine in solubilizing and enhancing insulin stability in reverse hexagonal mesophases. J. Colloid Interface Sci. 364, 379-387 (2011).
41. Rappolt, M. in Advances in planar lipid bilayers and liposomes. Vol. 5 (ed Leitmannova Lui, A.) Elsevier Inc., Amsterdam 253-283 (2006).
42. Rappolt, M., Cacho-Nerin, F., Morello, C., & Yaghmur, A. How the chain configuration governs the packing of inverted micelles in the cubic Fd 3 mphase. Soft Matter. 9, 6291-6300 (2013).
43. Kulkarni, C. V., Wachter, W., Iglesias-Salto, G., Engelskirchen, S., & Ahualli, S. Monoolein: a magic lipid? Phys. Chem. Chem. Phys. 13, 3004-3021 (2011).
44. Yaghmur, A., de Campo, L., Sagalowicz, L., Leser, M. E., & Glatter, O. Emulsified Microemulsions and Oil-Containing Liquid Crystalline Phases. Langmuir. 21, 569-577 (2005).
45. Kulkarni, C. V., & Glatter, O. in Self-Assembled Supramolecular Architectures: Lyotropic Liquid Crystals.Surface and Interfacial Chemistry. (ed Nissim Garti) Ch. 6, John Wiley & Sons, Inc. (2012).
46. Salonen, A., Muller, F. O., & Glatter, O. Internally Self-Assembled Submicrometer Emulsions Stabilized by Spherical Nanocolloids: Finding the Free Nanoparticles in the Aqueous Continuous Phase. Langmuir. 26, 7981-7987 (2010).
47. Guillot, S., Bergaya, F., de Azevedo, C., Warmont, F., & Tranchant, J. F. Internally structured pickering emulsions stabilized by clay mineral particles. J. Colloid Interface Sci. 333, 563-569 (2009).
48. Muller, F., Salonen, A., & Glatter, O. Monoglyceride-based cubosomes stabilized by Laponite: Separating the effects of stabilizer, pH and temperature. Colloids Surf., A. 358, 50-56 (2010).
49. Salonen, A., Muller, F. O., & Glatter, O. Dispersions of Internally Liquid Crystalline Systems Stabilized by Charged Disklike Particles as Pickering Emulsions: Basic Properties and Time-Resolved Behavior. Langmuir. 24, 5306-5314 (2008).
50. Gaunt, N. P., Patil-Sen, Y., Baker, M. J., & Kulkarni, C. V. Carbon nanotubes for stabilization of nanostructured lipid particles. Nanoscale. 7, 1090-1095 (2015).
51. Pickering, S. U. Emulsions. J. Chem. Soc. 91, 2001 (1907).
52. Ramsden, W. Separation of Solids in the Surface-Layers of Solutions and ’Suspensions’ (Observations on Surface-Membranes, Bubbles, Emulsions, and Mechanical Coagulation).-- Preliminary Account. Proceedings of the Royal Society of London. 72, 156-164 (1903).
53. Lin, Y. et al. Advances toward bioapplications of carbon nanotubes. J. Mater. Chem. 14, 527-541 (2004).
54. Saito, N. et al. Safe Clinical Use of Carbon Nanotubes as Innovative Biomaterials. Chem. Rev. 114, 6040-6079 (2014).
55. Pulskamp, K., Diabate, S., & Krug, H. F. Carbon nanotubes show no sign of acute toxicity but induce intracellular reactive oxygen species in dependence on contaminants. Toxicol. Lett. 168, 58-74 (2007).
56. Smart, S. K., Cassady, A. I., Lu, G. Q., & Martin, D. J. The biocompatibility of carbon nanotubes. Carbon. 44, 1034-1047 (2006).
57. Colvin, V. L. The potential environmental impact of engineered nanomaterials. Nat. Biotechnol. 21, 1166-1170 (2003).
58. Firme, C. P., III & Bandaru, P. R. Toxicity issues in the application of carbon nanotubes to biological systems. Nanomed-Nanotechnol. 6, 245-256 (2010).
59. Haddon, R. C. Carbon nanotubes. Accounts Chem. Res. 35, 997-997 (2002).
60. Kapralov, A. A. et al. Adsorption of Surfactant Lipids by Single-Walled Carbon Nanotubes in Mouse Lung upon Pharyngeal Aspiration. Acs Nano. 6, 4147-4156 (2012).
61. Wallace, E. J., & Mark, S. P. S. Carbon nanotube self-assembly with lipids and detergent: a molecular dynamics study. Nanotechnology. 20, 045101 (2009).
62. George, R. B. Chest medicine: essentials of pulmonary and critical care medicine. Lippincott Williams & Wilkins (2005).
63. Monteiro-Riviere, N. A., Nemanich, R. J., Inman, A. O., Wang, Y. Y., & Riviere, J. E. Multi-walled carbon nanotube interactions with human epidermal keratinocytes. Toxicol. Lett. 155, 377-384 (2005).
64. Shvedova, A. et al. Exposure to carbon nanotube material: assessment of nanotube cytotoxicity using human keratinocyte cells. J. Toxicol. Env. Heal. A. 66, 1909-1926 (2003).
65. Jia, G. et al. Cytotoxicity of carbon nanomaterials: single-wall nanotube, multi-wall nanotube, and fullerene. Environ. Sci. Technol. 39, 1378-1383 (2005).
66. Sato, Y. et al. Influence of length on cytotoxicity of multi-walled carbon nanotubes against human acute monocytic leukemia cell line THP-1 in vitro and subcutaneous tissue of rats in vivo. Mol. BioSyst. 1, 176-182 (2005).
67. Bottini, M. et al. Multi-walled carbon nanotubes induce T lymphocyte apoptosis. Toxicol. Lett. 160, 121-126 (2006).
68. Cui, D., Tian, F., Ozkan, C. S., Wang, M., & Gao, H. Effect of single wall carbon nanotubes on human HEK293 cells. Toxicol. Lett. 155, 73-85 (2005).
69. Huang, T., Toraya, H., Blanton, T., & Wu, Y. X-ray powder diffraction analysis of silver behenate, a possible low-angle diffraction standard. J. Appl. Crystallogr. 26, 180-184 (1993).
70. Bokobza, L., & Zhang, J. Raman spectroscopic characterization of multiwall carbon nanotubes and of composites. Express Polym. Lett. 6, 601-608 (2012).
71. Zhao, Q., & Wagner, H. D. Raman spectroscopy of carbon-nanotube-based composites. Philos. Trans. R. Soc. London, Ser. A-Math. Phys. Eng. Sci. 362, 2407-2424 (2004).
72. Douroumis, D., Fatouros, D. G., Bouropoulos, N., Papagelis, K., & Tasis, D. Colloidal stability of carbon nanotubes in an aqueous dispersion of phospholipid. Int. J. Nanomed. 2, 761-766 (2007).
73. Worthington, R. J., & Melander, C. Combination approaches to combat multidrug-resistant bacteria. Trends Biotechnol. 31, 177-184 (2013)